(GBLB) Groep Brussel Lambert - BR
Sector: Financial Services | Industry: Asset Management | Exchange: BR (Belgium) | Market Cap: 9.704m EUR | Total Return: 18.5% in 12m
Avg Turnover: 7.75M
Rev. Trend: -62.9%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
Groupe Bruxelles Lambert SA (GBL) is a Brussels-based investment holding company with a diversified portfolio spanning industrial minerals, consumer goods, and healthcare services across Europe and North America. The firm operates through distinct segments including Imerys, Affidea, and Sanoptis, as well as its proprietary investment arms GBL Capital and Sienna Investment Managers.
As a multi-sector holding company, GBL utilizes a long-term capital appreciation model, often taking significant minority or controlling stakes to influence corporate governance and strategic direction. This business model typically provides investors with exposure to private equity-style assets and diversified industrial operations through a single public security. For a more granular look at the underlying asset valuations and historical performance, consider reviewing the detailed metrics on ValueRay.
The company maintains a focus on geographical diversification and sector-specific platforms to mitigate regional economic volatility. Founded in 1902, GBL remains one of the largest listed investment vehicles in Europe, categorized within the Financials sector under the Multi-Sector Holdings industry group.
- Net Asset Value discount narrows through aggressive share buyback programs
- Private asset portfolio expansion increases exposure to healthcare and business services
- Imerys operational margins fluctuate with global industrial demand and energy costs
- Sienna Investment Managers growth scales third-party assets under management and fee income
| Net Income: -243.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -2.44 > 1.0 |
| NWC/Revenue: 23.07% < 20% (prev 42.67%; Δ -19.60% < -1%) |
| CFO/TA 0.03 > 3% & CFO 747.1m > Net Income -243.7m |
| Net Debt (6.67b) to EBITDA (1.13b): 5.90 < 3 |
| Current Ratio: 3.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (69.1m) vs 12m ago -54.42% < -2% |
| Gross Margin: 53.55% > 18% (prev 48.16%; Δ 5.39% > 0.5%) |
| Asset Turnover: 28.87% > 50% (prev 24.06%; Δ 4.81% > 0%) |
| Interest Coverage Ratio: 1.04 > 6 (EBIT TTM 509.1m / Interest Expense TTM 489.8m) |
| A: 0.07 (Total Current Assets 2.43b - Total Current Liabilities 679.4m) / Total Assets 25.1b |
| B: 0.28 (Retained Earnings 6.95b / Total Assets 25.1b) |
| C: 0.02 (EBIT TTM 509.1m / Avg Total Assets 26.3b) |
| D: 0.99 (Book Value of Equity 11.6b / Total Liabilities 11.7b) |
| Altman-Z'' = 2.53 = A |
| DSRI: 0.92 (Receivables 670.0m/637.1m, Revenue 7.58b/6.61b) |
| GMI: 0.90 (GM 48.16% / 53.55%) |
| AQI: 1.15 (AQ_t 0.77 / AQ_t-1 0.67) |
| SGI: 1.15 (Revenue 7.58b / 6.61b) |
| TATA: -0.04 (NI -243.7m - CFO 747.1m) / TA 25.1b) |
| Beneish M = -3.00 (Cap -4..+1) = A |
As of June 20, 2026, the stock is trading at EUR 79.20 with a total of 307,970 shares traded.
Over the past week, the price has changed by -0.19%,
over one month by +1.73%,
over three months by +7.39% and
over the past year by +18.52%.
Groep Brussel Lambert has no consensus analysts rating.
P/E Forward = 25.7069
P/S = 1.5014
P/B = 0.8337
P/EG = 0.5212
Revenue TTM = 7.58b EUR
EBIT TTM = 509.1m EUR
EBITDA TTM = 1.13b EUR
Long Term Debt = 6.78b EUR (from longTermDebt, last quarter)
Short Term Debt = 679.4m EUR (from shortTermDebt, last quarter)
Debt = 8.21b EUR (from shortLongTermDebtTotal, last quarter) + Leases 764.1m
Net Debt = 6.67b EUR (calculated: Debt 8.21b - CCE 1.54b)
Enterprise Value = 16.4b EUR (9.70b + Debt 8.21b - CCE 1.54b)
Interest Coverage Ratio = 1.04 (Ebit TTM 509.1m / Interest Expense TTM 489.8m)
EV/FCF = 237.4x (Enterprise Value 16.4b / FCF TTM 69.0m)
FCF Yield = 0.42% (FCF TTM 69.0m / Enterprise Value 16.4b)
FCF Margin = 0.91% (FCF TTM 69.0m / Revenue TTM 7.58b)
Net Margin = -3.21% (Net Income TTM -243.7m / Revenue TTM 7.58b)
Gross Margin = 53.55% ((Revenue TTM 7.58b - Cost of Revenue TTM 3.52b) / Revenue TTM)
Gross Margin QoQ = 63.41% (prev 42.22%)
Tobins Q-Ratio = 0.65 (Enterprise Value 16.4b / Total Assets 25.1b)
Interest Expense / Debt = 5.96% (Interest Expense 489.8m / Debt 8.21b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = 381.8m (EBIT 509.1m * (1 - 25.00%))
Current Ratio = 3.58 (Total Current Assets 2.43b / Total Current Liabilities 679.4m)
Debt / Equity = 0.71 (Debt 8.21b / totalStockholderEquity, last quarter 11.6b)
Debt / EBITDA = 5.90 (Net Debt 6.67b / EBITDA 1.13b)
Debt / FCF = 96.72 (Net Debt 6.67b / FCF TTM 69.0m)
Total Stockholder Equity = 13.5b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.93% (Net Income -243.7m / Total Assets 25.1b)
RoE = -1.80% (Net Income TTM -243.7m / Total Stockholder Equity 13.5b)
RoCE = 2.50% (EBIT 509.1m / Capital Employed (Equity 13.5b + L.T.Debt 6.78b))
RoIC = 1.55% (NOPAT 381.8m / Invested Capital 24.7b)
WACC = 5.92% (E(9.70b)/V(17.9b) * Re(7.14%) + D(8.21b)/V(17.9b) * Rd(5.96%) * (1-Tc(0.25)))
Discount Rate = 7.14% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -60.0 | Cagr: -28.13%
[DCF] Terminal Value 73.10% ; FCFF base≈340.2m ; Y1≈298.3m ; Y5≈241.0m
[DCF] Fair Price = N/A (negative equity: EV 3.87b - Net Debt 6.67b = -2.81b; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: -62.86 | Revenue CAGR: -6.78% | SUE: 0.26 | # QB: 0
EPS current Year (2026-12-31): EPS=2.35 | Chg30d=-11.65% | Revisions=-20% | GrowthEPS=-17.8% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=2.37 | Chg30d=-12.87% | Revisions=-20% | GrowthEPS=+0.9% | GrowthRev=+3.0%